Biomarker driven treatment of selected NSCLC: EGFR - EGFR TKI in mutant EGFR NSCLC - Mechanisms of resistance and drugs in development

Date 08 July 2015
Event ESMO Preceptorship on NSCLC 2015
Session Session 4 - Biomarker driven treatment
Topics Anti-Cancer Agents & Biologic Therapy
Drug Development
Non-Small-Cell Lung Cancer, Metastatic
Presenter Federico Cappuzzo
Authors F. Cappuzzo
  • NA - NA/IT